Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Immuno-Oncology Technology|February 21, 2025
Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeuticsB E Nelson, A Naing, S Fu, et al.Immuno-Oncology Technology|December 19, 2024
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapyM Willemsen, J Bulgarelli, S K Chauhan, et al.Immuno-Oncology Technology|February 17, 2022
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platformV H Koelzer, P Herzig, I Zlobec, et al.Immuno-Oncology Technology|October 27, 2023
Corrigendum to "Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies": [Immuno-Oncology and Technology 10 (2023) 100394]J R Cox, M Jennings, C Lenahan, et al.Immuno-Oncology Technology|July 24, 2023
Immuno-oncology approaches in uveal melanoma: tebentafusp and beyondC Gerard, B Shum, P Nathan, et al.Immuno-Oncology Technology|July 24, 2023
Engineering enhanced chimeric antigen receptor-T cell therapy for solid tumorsA Neeser, R Ramasubramanian, C Wang, et al.Immuno-Oncology Technology|August 31, 2022
Cell Squeeze: driving more effective CD8 T-cell activation through cytosolic antigen deliveryJ C Park, H Bernstein, S Loughhead, et al.Immuno-Oncology Technology|June 27, 2022
The emerging role of γδ T cells in cancer immunotherapyOliver Nussbaumer, Michael KoslowskiImmuno-Oncology Technology|April 30, 2026
Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitorsS Egyhazi Brage, F Costa Svedman, M Bergqvist, et al.Immuno-Oncology Technology|March 13, 2023
TCR sequencing: applications in immuno-oncology researchÁ F Sanromán, K Joshi, L Au, et al.Pageof 10